James T Lafrance - Net Worth and Insider Trading
James T Lafrance Net Worth
The estimated net worth of James T Lafrance is at least $67,353 dollars as of 2024-04-24. James T Lafrance is the Director of Aspira Womens Health Inc and owns about 19,868 shares of Aspira Womens Health Inc (AWH) stock worth over $67,353. Details can be seen in James T Lafrance's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James T Lafrance has not made any transactions after 2018-08-20 and currently still holds the listed stock(s).
Transaction Summary of James T Lafrance
James T Lafrance Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James T Lafrance owns 2 companies in total, including HTG Molecular Diagnostics Inc (HTGMQ) , and Aspira Womens Health Inc (AWH) .
Click here to see the complete history of James T Lafrance’s form 4 insider trades.
Insider Ownership Summary of James T Lafrance
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HTGMQ | HTG Molecular Diagnostics Inc | 2015-12-01 | director |
| AWH | Aspira Womens Health Inc | 2018-08-20 | director |
James T Lafrance Latest Holdings Summary
James T Lafrance currently owns a total of 1 stock. James T Lafrance owns 19,868 shares of Aspira Womens Health Inc (AWH) as of August 20, 2018, with a value of $67,353.
Latest Holdings of James T Lafrance
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AWH | Aspira Womens Health Inc | 2018-08-20 | 19,868 | 3.39 | 67,353 |
Holding Weightings of James T Lafrance
James T Lafrance Form 4 Trading Tracker
According to the SEC Form 4 filings, James T Lafrance has made a total of 0 transactions in Aspira Womens Health Inc (AWH) over the past 5 years. The most-recent trade in Aspira Womens Health Inc is the sale of 1,560 shares on August 20, 2018, which brought James T Lafrance around $11,700.
Insider Trading History of James T Lafrance
- 1
James T Lafrance Trading Performance
GuruFocus tracks the stock performance after each of James T Lafrance's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James T Lafrance is 38.49%. GuruFocus also compares James T Lafrance's trading performance to market benchmark return within the same time period. The performance of stocks bought by James T Lafrance within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James T Lafrance's insider trading performs compared to the benchmark.
Performance of James T Lafrance
Average Return
7.19%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 74.1 | 38.49 | -5.04 | 7.19 | -25.57 | -15.12 |
| Relative Return to S&P 500(%) | 72.16 | 35.8 | -9.9 | -7.19 | -34.31 | -28.28 |
James T Lafrance Ownership Network
Ownership Network List of James T Lafrance
Ownership Network Relation of James T Lafrance
James T Lafrance Owned Company Details
What does HTG Molecular Diagnostics Inc do?
Who are the key executives at HTG Molecular Diagnostics Inc?
James T Lafrance is the director of HTG Molecular Diagnostics Inc. Other key executives at HTG Molecular Diagnostics Inc include Senior VP of Therapeutics Stephen Barat , 10 percent owner L5 Capital Inc. , and SVP/Chief Commercial Officer Byron Lawson .
HTG Molecular Diagnostics Inc (HTGMQ) Insider Trades Summary
Over the past 18 months, James T Lafrance made no insider transaction in HTG Molecular Diagnostics Inc (HTGMQ). Other recent insider transactions involving HTG Molecular Diagnostics Inc (HTGMQ) include a net sale of 888 shares made by Stephen Barat ,
In summary, during the past 3 months, insiders sold 0 shares of HTG Molecular Diagnostics Inc (HTGMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 888 shares of HTG Molecular Diagnostics Inc (HTGMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 888 shares.
HTG Molecular Diagnostics Inc (HTGMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
HTG Molecular Diagnostics Inc Insider Transactions
James T Lafrance Mailing Address
Above is the net worth, insider trading, and ownership report for James T Lafrance. You might contact James T Lafrance via mailing address: 1910 Innovation Park Dr, Tucson Az 85737.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
